Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Active Comparator-Controlled Phase Ⅲ Trial to Evaluate the Immunogenicity and Safety of the Group ACYW135 Meningococcal Conjugate Vaccine in Population Aged 6 to 11 Months
Conditions
Interventions
experimental vaccine
Active Comparator vaccine
Start Date
March 22, 2026
Primary Completion Date
April 1, 2027
Completion Date
January 1, 2028
Last Updated
April 1, 2026
NCT07203755
NCT05935176
NCT07505836
NCT01266993
Lead Sponsor
Sinovac Biotech Co., Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions